Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Journal of International Oncology
>
2016
>
43
>
3
Volume:
43
Issue:
3
1. Concurrent chemoradiotherapy for 90 patients in different parts of esophageal carcinoma
Page:177—179
2. Plasma D-dimer in the application of the tumor
Page:198—200
3. Advances in the study of gastric cancer related long noncoding RNA
Page:220—222
4. The immune status of pancreatic cancer patients
Page:223—225
5. Expression and clinical significance of RNA-binding protein Musashi1 in colorectal cancer
Page:226—228
6. The research progress of colorectal cancer screening methods
Page:229—231
7. Influence of S100A6 gene RNA interference on the biological behaviors of A549 lung adenocarcinoma cells
Page:161—166
8. Expressions and clinical significances of TRAIL and its receptors in non-small cell lung cancer
Page:167—170
9. Expressions and clinical significances of Hepcidin, BMP6 and HJV in gastric cancer
Page:180—183
10. Expressions of CD147 and EGFR protein and their relationship with metastasis and prognosis of gastric cancer
Page:184—187
11. Expression and significance of Sirtuin 1 in human colorectal cancer
Page:188—192
12. Expressions and clinical significances of IL-10 and IL-18 levels in patients with cervical intraepithelial neoplasias and cervical carcinoma
Page:193—197
13. Changes of volume and dose in target volume and organ at risk for nasopharyngeal carcinoma during intensity modulated radiotherapy
Page:201—203
14. Advance of radioiodine antagonist related gene of differentiated thyroid carcinoma
Page:204—206
15. Influencing factors of lateral lymph node metastasis in papillary thyroid carcinoma
Page:207—209
16. Adjuvant endocrine therapy for breast cancer
Page:210—212
17. Effect of adjuvant treatment of breast cancer in childbearing age on ovarian function
Page:213—215
18. Research status of targeted drug and whole brain radiotherapy for non-small cell lung cancer with brain metastasis
Page:216—219
19. Reasearch progress of cervical cancer screening
Page:232—235
20. Targeted drug therapy for bladder cancer
Page:236—238